873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models

873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models

Bibliographic Details
Main Authors:	Man Zhang, Jin Liu, Celia Chen, Xin Cheng, Feng Ren, Jianyu Wu, Luoheng Qin, Supriya Bavadekar, Sujata Rao, Alex Zhavoronkov
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Identification of novel pyrrolopyrimidine and pyrrolopyridine derivatives as potent ENPP1 inhibitors
by: Hee Jin Jeong, et al.
Published: (2022-12-01)

897-G SR-8541A, a small molecule inhibitor of ENPP1, enhances the effect of immune checkpoint inhibitors in a colorectal cancer model
by: Sunil Sharma, et al.
Published: (2023-11-01)

Modeling Immune Checkpoint Inhibitor Efficacy in Syngeneic Mouse Tumors in an Ex Vivo Immuno-Oncology Dynamic Environment
by: Daniel T. Doty, et al.
Published: (2020-09-01)

864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation
by: Sandeep Goyal, et al.
Published: (2023-11-01)

Development of Novel Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Tumor Immunotherapy
by: Xiang Wang, et al.
Published: (2022-06-01)

Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells
by: Michael Chamo, et al.
Published: (2023-01-01)

CTLA-2 Alpha Is a Potent Inhibitor of Angiogenesis in Murine Ocular Tissue
by: Kazuichi Maruyama, et al.
Published: (2021-03-01)

Characterization of immune cell populations in syngeneic murine tumor models
by: Sofie Snipstad, et al.
Published: (2023-05-01)

AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model
by: Avijit Goswami, et al.
Published: (2022-10-01)

ANGPTL2 promotes immune checkpoint inhibitor-related murine autoimmune myocarditis
by: Haruki Horiguchi, et al.
Published: (2023-09-01)

Structure-based virtual screening and in vitro validation of inhibitors of cyclic dinucleotide phosphodiesterases ENPP1 and CdnP
by: Akshay Rohilla, et al.
Published: (2024-01-01)

Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
by: Jasneet Kaur Khalsa, et al.
Published: (2021-02-01)

1077 Preclinical and IND-enabling studies of TXN10128, an ENPP1 inhibitor, for clinical evaluation in patients with solid tumor
by: Jun Yong Choi, et al.
Published: (2023-11-01)

Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer
by: Shonagh Russell, et al.
Published: (2022-08-01)

Checkpoint Inhibitors and Hepatotoxicity
by: Stephen D. H. Malnick, et al.
Published: (2021-01-01)

Checkpoint Inhibitors and the Gut
by: Tuan Tran, et al.
Published: (2022-02-01)

HDAC Inhibition to Prime Immune Checkpoint Inhibitors
by: Edith Borcoman, et al.
Published: (2021-12-01)

Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain
by: Chan, MC, et al.
Published: (2015)

Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma
by: Gayathri Vijayakumar, et al.
Published: (2019-11-01)

An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma
by: Felicity C. Stark, et al.
Published: (2017-10-01)

A CMOS PSR Enhancer with 87.3 mV PVT-Insensitive Dropout Voltage for Sensor Circuits
by: Jianyu Zhang, et al.
Published: (2021-11-01)

A CMOS PSR enhancer with 87.3 mV PVT-insensitive dropout voltage for sensor circuits
by: Zhang, Jianyu, et al.
Published: (2022)

Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor
by: Qureshi Asaf A, et al.
Published: (2012-07-01)

Identification of Piperlongumine as Potent Inhibitor of Necroptosis
by: He X, et al.
Published: (2023-05-01)

The Azadirachtins: potent insect growth inhibitors
by: Heinz Rembold
Published: (1987-01-01)

Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models
by: Yasuhiro Maruoka, et al.
Published: (2020-09-01)

Slow-cycling murine melanoma cells display plasticity and enhanced tumorigenicity in syngeneic transplantation assay
by: Anna Kusienicka, et al.
Published: (2023-02-01)

ENPP1 processes protein ADP-ribosylation in vitro.
by: Palazzo, L, et al.
Published: (2016)

Investigation of the role of ENPP1 and TNAP genes in chondrocalcinosis.
by: Zhang, Y, et al.
Published: (2007)

<i>ENPP2</i> Methylation in Health and Cancer
by: Maria Panagopoulou, et al.
Published: (2021-11-01)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
by: Huang JT, et al.
Published: (2022-11-01)

31,873 pelajar daftar masuk 10 universiti
by: Berita, Harian
Published: (2014)

ENPP2 inhibitor improves proliferation in AOM/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition
by: Junling Yan, et al.
Published: (2023-09-01)

Immune Checkpoint Inhibitors and Lupus Erythematosus
by: Hans Vitzthum von Eckstaedt, et al.
Published: (2024-02-01)

Editorial: Nephrotoxicity of immune checkpoint inhibitors
by: Tess Van Meerhaeghe, et al.
Published: (2024-01-01)

Cardiovascular complications of immune checkpoint inhibitors
by: A. A. Kulievа, et al.
Published: (2020-04-01)

Mechanisms of action for different checkpoint inhibitors
by: Pedro Berraondo
Published: (2019-06-01)

Cardiotoxicity Associated with Immune Checkpoint Inhibitors
by: Shintaro Minegishi, et al.
Published: (2023-11-01)

Immune Checkpoint Inhibitors in Prostate Cancer
by: Shobi Venkatachalam, et al.
Published: (2021-05-01)

Checkpoint Inhibitor-Induced Colitis: An Update
by: Giuseppe Losurdo, et al.
Published: (2023-05-01)